English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Review examines strategies to address antibody drug conjugate resistance in cancer treatment
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Open-source tool Talos enables faster rare disease diagnoses through genomic data reanalysis
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Early study finds new oral drug safe for chronic heart failure patients
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Researchers identify new approach to modulate spinal cord scar cells after injury
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

FDA approves palbociclib combination for advanced HR-positive HER2-positive breast cancer
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

BIO CEO Crowley and DOD doctor Overton considered top candidates for FDA commissioner
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Review finds limited evidence that yo-yo dieting causes lasting health harm
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

AbbVie acquires Apogee Therapeutics as biopharma M&A activity continues in 2026

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes